University of Illinois at Urbana-Champaign

Most homemade masks are doing a great job, even when we sneeze, study finds

Newswise — CHAMPAIGN, Ill. — Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing. Many of these studies focus on the transfer of tiny aerosol particles; however, researchers say that speaking, coughing and sneezing generates larger droplets that carry virus particles. Because of this, mechanical engineer Taher Saif said the established knowledge may not be enough to determine the effectiveness of some fabrics used in homemade masks.

Saif, a mechanical science and engineering professor at the University of Illinois, Urbana-Champaign, led a study that examined the effectiveness of common household fabrics in blocking droplets. The findings are published in the journal Extreme Mechanics Letters.

Aerosol particles are typically classified as less than 5 micrometers, and lie in the range of hundreds of nanometers. However, larger droplets – up to about 1 millimeter in diameter – can  also be expelled when an individual speaks, coughs or sneezes. These larger droplets pose a problem because, with sufficient momentum, they can squeeze through the pores of some fabrics, break into smaller droplets and become airborne.

However, for an individual to feel compelled to wear a mask, it must be comfortable and breathable, the researchers said.

“A mask made out of a low-breathability fabric is not only uncomfortable, but can also result in leakage as the exhaled air is forced out around contours of a face, defeating the purpose of the mask and providing a false sense of protection,” Saif said. “Our goal is to show that many common fabrics exploit the trade-off between breathability and efficiency of blocking droplets – large and small.”

The team tested the breathability and droplet-blocking ability of 11 common household fabrics, using a medical mask as a benchmark. The fabrics selected ranged from new and used garments, quilted cloths, bedsheets and dishcloth material. The researchers then characterized the fabrics in terms of their construction, fiber content, weight, thread count, porosity and water-absorption rate.

“Testing the breathability of these fabrics was the easy part,” Saif said. “We simply measured the rate of airflow through the fabric. Testing the droplet-blocking ability is a bit more complicated.”

In the lab, the researchers fill the nozzle of an inhaler with distilled water seeded with easy-to-find 100-nanometer diameter fluorescent particles – which happens to be the size of a novel coronavirus particle. When puffed, the inhaler forces the water through the nozzle and generates high-momentum droplets that collect on a plastic dish placed in front of the inhaler. To test the fabrics, the researchers repeat this process with the various materials placed over the collection dishes.

“We count the number of nanoparticles landing on the dish using a high-resolution confocal microscope. We can then use the ratio of the number collected with and without the fabric to give us a measure of droplet-blocking efficiency,” Saif said.

The team also measured the velocity and size of the particles expelled from the inhaler using high-speed video.

Their analyses revealed that droplets leave the inhaler at about 17 meters per second. Droplets released by speaking, coughing and sneezing have velocities within the range of 10 to 40 meters per second, the researchers said.

In terms of size, the high-speed video detected droplets with diameters in the 0.1 to 1 millimeter range, matching that of the larger-sized droplets released by speaking, coughing and sneezing.

 “We found that all of the fabrics tested are considerably effective at blocking the 100 nanometer particles carried by high-velocity droplets similar to those that may be released by speaking, coughing and sneezing, even as a single layer,” Saif said. “With two or three layers, even the more permeable fabrics, such as T-shirt cloth, achieve droplet-blocking efficiency that is similar to that of a medical mask, while still maintaining comparable or better breathability.

“Our experimental platform offers a way to test fabrics for their blocking efficiency against the small – and now – larger droplets that are released by human respiratory events.”

###

 

U. of I. engineering students Onur Aydin, Bashar Emon, Shyuan Cheng, Liu Hong and Leonardo P. Chamorro participated in this study. Saif also is affiliated with bioengineering, the Holonyak Micro and Nanotechnology Lab, the Beckman Institute for Advanced Science and Technology, the Carl R. Woese Institute for Genomic Biology and the Carle Illinois College of Medicine at Illinois.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 4146
Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 4146

close
0.86218